Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hidradenitis Suppurativa: early-phase trial registry
29 of 53 indexed Hidradenitis Suppurativa trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #265 of 28,707 conditions by registered trial count.
53 US clinical trials · 29 currently recruiting · #265 of 28,707 conditions by registered trial count
Hidradenitis Suppurativa: 53 US clinical trials tracked, 29 recruiting.
Hidradenitis Suppurativa is the subject of 53 registered US clinical trials on ClinicalTrials.gov, 29 of them currently open to new participants. 14 are in Phase 3-4 (later-stage) and 24 in Phase 1-2 (earlier-stage). The most active sponsor is Novartis Pharmaceuticals, running 5 of these trials.
Enrollment posture brief
Registry condition hidradenitis-suppurativa
OPEN 29 | RECR 55% | LATE 14 | EARLY 24 | RANK #265 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Anatomic Stage I Breast Cancer AJCC v8 (55% recruiting · 64 trials)
Hidradenitis Suppurativa lists 29 open slots (55% of 53 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hidradenitis Suppurativa on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hidradenitis Suppurativa is recruiting above its size-band peers.
29 of 53 indexed trials (54.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hidradenitis Suppurativa trials is spread across many organizations.
Novartis Pharmaceuticals accounts for 5 of 53 trials (9.4%). 29 distinct sponsors appear on at least one study for this condition label.
-
Typical Hidradenitis Suppurativa enrolment sits around 144 participants.
Median target enrolment is 144 among the 53 trials that report a genuine target (sentinel values excluded). 26 of those (49.1%) plan for fewer than 100 participants.
-
Hidradenitis Suppurativa research is mostly interventional.
45 interventional and 8 observational studies make up this index (84.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
53 total, page 2 of 2
Hidradenitis Suppurativa (HS) Tunneling Wounds
University of Miami
NCT04648631
A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Incyte Corporation
NCT03569371
Anakinra as a Treatment for Hydradenitis Suppurativa
University of California, San Francisco
NCT01516749
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 19 |
| Phase 3 | 14 |
Top Sponsors
Named interventions
Most-linked intervention names on Hidradenitis Suppurativa records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hidradenitis Suppurativa trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hidradenitis Suppurativa page
53 registered trials, 29 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 29 Hidradenitis Suppurativa trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Novartis Pharmaceuticals sponsors the most Hidradenitis Suppurativa trials on record, review their full trial history before evaluating a specific study. See Novartis Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hidradenitis Suppurativa condition card totals 53 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.